Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
150.00
-1.27 (-0.84%)
Dec 5, 2025, 4:00 PM EST - Market closed

Belite Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-62.39-36.14-31.63-12.65-9.67-5.75
Depreciation & Amortization
0.470.450.40.20.030.02
Loss (Gain) From Sale of Assets
-----0.01-
Loss (Gain) From Sale of Investments
-0.05-0.05----
Stock-Based Compensation
31.418.993.821.481.531.36
Other Operating Activities
-4.36-3.61----
Change in Accounts Receivable
-0.02-0.02-0.03-0
Change in Accounts Payable
-0.010.01--0.040.05-0.02
Change in Other Net Operating Assets
3.731.1-2.41-0.420.6-0.05
Operating Cash Flow
-31.2-29.23-29.84-11.46-7.47-4.44
Capital Expenditures
--0.12-0.06-0.39-0.07-0.02
Sale of Property, Plant & Equipment
----0.02-
Sale (Purchase) of Intangibles
-0.01-0.04----
Investment in Securities
-27.38-110.42----
Investing Cash Flow
-27.39-110.57-0.06-0.39-0.06-0.02
Short-Term Debt Issued
-----0.13
Total Debt Issued
-----0.13
Short-Term Debt Repaid
------2.45
Total Debt Repaid
------2.45
Net Debt Issued (Repaid)
------2.32
Issuance of Common Stock
45.9858.277.1937.990.230.59
Other Financing Activities
146.9125.39-1.23-1.03-0.82-
Financing Cash Flow
192.8983.675.9636.96-0.5828.06
Foreign Exchange Rate Adjustments
-0.06-0.270.01-0.37-0.160
Net Cash Flow
134.24-56.4846.0724.75-8.2723.6
Free Cash Flow
-31.2-29.35-29.9-11.85-7.55-4.46
Free Cash Flow Per Share
-0.96-0.96-1.12-0.59-0.79-0.51
Cash Interest Paid
---0.02-0.02
Cash Income Tax Paid
-0.010.01---
Levered Free Cash Flow
103.46-13.42-15.3-7.1-4.01-
Unlevered Free Cash Flow
103.48-13.4-15.28-7.09-4.01-
Change in Working Capital
3.711.13-2.43-0.490.64-0.07
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q